GlassScriptPhysician profile
Felix Spiegel
NPI 1013051960
$15,835.61
in general payments reported to CMS, 2019-2025
8 companies · $16.25 in 2025
The $16.25 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,380 · 2020: $10K · 2021: $86.62 · 2022: $1,789 · 2023: $753 · 2024: $1,414 · 2025: $16.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337 · Travel and Lodging: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.20 |
| Travel and Lodging | $846.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,041.01 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $1,230.62 | 2019-2024 | Echelon; Endopath, Vistaseal, Harmonic |
| Medical Device Business Services, INC. | $1,043.60 | 2024 | Echelon Flex |
| Teleflex LLC | $301.99 | 2023 | Titan Sgs Standard Gastric Stapler, Titan Sgs |
| Novo Nordisk INC | $102.66 | 2022 | |
| Baxter Healthcare | $81.81 | 2020-2022 | |
| Lilly USA, LLC | $17.67 | 2024 | Zepbound |
| Intra-Sana Laboratories | $16.25 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Spiegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.